COLTENE Holding AG/Fr. CLTN
1D1W1MYTD1Y5YMAX
Capital at risk
About COLTENE Holding AG
COLTENE Holding AG is a Swiss company operating in the dental industry, providing a broad range of products and services for dental practitioners and laboratories. The company's core offerings include dental consumables, tools, and equipment that support restoration, endodontics, and treatment hygiene. Headquartered in Altstätten, Switzerland, COLTENE serves a global customer base with manufacturing sites in Switzerland, Germany, the USA, and Hungary. The company's strategic positioning is enhanced by its focus on innovative dental solutions and its extensive product portfolio, catering to various aspects of dental care and procedures.
- Ticker
- Fr. CLTN
- Sector
- Health
- Primary listing
- XSWX
- Employees
- 1,137
- Headquarters
- Altstätten, Switzerland
- Website
- www.coltene.com
CLTN Metrics
BasicAdvanced
CHF 275M
19.00
CHF 2.47
0.84
CHF 2.00
0.60%
Price and volume
Market cap
CHF 275M
Beta
0.84
52-week high
CHF 59.00
52-week low
CHF 42.60
Average daily volume
2.2K
Dividend rate
CHF 2.00
Financial strength
Current ratio
1.477
Quick ratio
0.848
Long term debt to equity
0
Total debt to equity
0.643
Dividend payout ratio (TTM)
81.09%
Profitability
EBITDA (TTM)
25.026
Gross margin (TTM)
64.75%
Net profit margin (TTM)
6.27%
Operating margin (TTM)
8.19%
Effective tax rate (TTM)
17.88%
Revenue per employee (TTM)
CHF 210,000
Management effectiveness
Return on assets (TTM)
6.57%
Return on equity (TTM)
16.04%
Valuation
Price to earnings (TTM)
18.995
Price to revenue (TTM)
1.191
Price to book
2.95
Price to tangible book (TTM)
3.16
Price to free cash flow (TTM)
21.112
Free cash flow yield (TTM)
4.74%
Free cash flow per share (TTM)
2.226
Dividend yield (TTM)
4.26%
Forward dividend yield
0.60%
Growth
Revenue change (TTM)
-2.45%
Earnings per share change (TTM)
3.46%
3-year revenue growth (CAGR)
-3.78%
10-year revenue growth (CAGR)
4.12%
3-year earnings per share growth (CAGR)
-14.80%
10-year earnings per share growth (CAGR)
-4.63%
3-year dividend per share growth (CAGR)
-15.37%
10-year dividend per share growth (CAGR)
-0.95%
Bulls say / Bears say
Sales grew 0.8% in local currencies in H1 despite headwinds, with market-share gains in EMEA and infection control. This suggests the business is holding its position while weaker regions and currency effects distort reported growth. (COLTENE Group, Quartr)
Free cash flow improved to CHF 4.8 million from negative CHF 0.3 million a year earlier, helped by better inventory and working-capital management. Stronger cash conversion gives COLTENE more flexibility to invest and support its dividend policy. (Quartr, COLTENE Group)
New products such as the HYDRIM washer and CalciSeal sealer are gaining traction, while other launches including Jeni and Synthex broaden the workflow offering. If adoption continues, these products could help COLTENE outgrow the 1–3% dental market and move towards its longer-term margin target. (Yahoo Finance, Dental Tribune)
H1 EBIT fell 23.6% and the margin dropped to 5.1% from 6.4%. Lower gross margins, adverse currency movements, higher material and logistics costs, and energy prices are pressuring profitability. (Quartr, Vermögenszentrum)
Demand remains uneven: North America, Asia and Latin America declined in local currencies, while US distributor destocking hurt dental preservation and treatment auxiliaries. Cautious orders for higher-priced infection-control equipment add to the risk of a slow recovery. (Yahoo Finance, MarketScreener)
Commercial execution has been slower than planned, requiring changes to the sales and marketing organisation. The FY 2026 margin target of 9–10% and the 13–15% medium-term goal therefore depend heavily on a stronger second half and successful execution. (Yahoo Finance, Seeking Alpha)
Data summarised monthly by Lightyear AI. Last updated on 20 Sept 2026.
CLTN Financial Performance
Revenues and expenses
CLTN Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.